<DOC>
	<DOCNO>NCT01806259</DOCNO>
	<brief_summary>Do use Ketorolac one intravenous injection moment operative incision reduce number recurrence patient advance breast cancer without inflammation sign .</brief_summary>
	<brief_title>Ketorolac Breast Cancer Surgery</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Written inform Consent age : 1885 year weight : 50100 kg Neutrophils / Lymphocytes ratio &gt; 4 and/or `` triple negative '' histological status and/or Positive lymph node Previous cancer ( behalf basocellular skin cancer situ uterine cervix cancer ) Non compliance refusal protocol Positive Pregnancy test Childbearing breastfeed mother Contraindication NSAIDs NSAIDs intake 5 day randomisation NSAIDs use plan 30 day randomisation Non curative surgery ( T4 M1 tumor classification )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>